Can FDA Be a Driving Force to Increase Access to Innovative Biomedical Technologies?

The United States is at a critical moment for the advancement of the biomedical industry. Despite the struggling U.S. economy, American pharmaceutical, medical device and biotech companies continue to maintain a competitive advantage in the global marketplace. Our track record of innovation includes not only breakthrough technologies that have created new therapeutic paradigms, but also a steady pace of product enhancements that over time have resulted in major improvements in health outcomes.

Click the link below to read the full alert.